NCT02515799View on ClinicalTrials.gov

Mucolytic Effectiveness of Tacholiquine ® in Chronic Bronchitis

PHASE4CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

July 31, 2015

Conditions
Bronchitis, ChronicPulmonary Disease, Chronic Obstructive
Interventions
DRUG

Tacholiquine

Inhaled Tacholiquine ®1% - 5ml

OTHER

Placebo

Inhaled Placebo

Trial Locations (1)

60596

Medaimun GmbH, Frankfurt/M

All Listed Sponsors
collaborator

Medaimun GmbH

OTHER

lead

bene-Arzneimittel GmbH

INDUSTRY

NCT02515799 - Mucolytic Effectiveness of Tacholiquine ® in Chronic Bronchitis | Biotech Hunter | Biotech Hunter